Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shota Ogura"'
Autor:
Yoei Miyabe, Kazunori Karasawa, Kenichi Akiyama, Shota Ogura, Tomo Takabe, Naoko Sugiura, Momoko Seki, Yuko Iwabuchi, Norio Hanafusa, Keiko Uchida, Kosaku Nitta, Takahito Moriyama
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract The Oxford classification of IgA nephropathy (IgAN) can evaluate each MEST-C score individually. We analysed a new grading system that utilised the total MEST-C score in predicting renal prognosis. Altogether, 871 IgAN patients were classifi
Externí odkaz:
https://doaj.org/article/66d9308949a64520b8a80b8d78f765f7
Publikováno v:
Clinical and Experimental Nephrology. 25:1103-1110
Tonsillectomy and steroid pulse therapy (TSP) for immunoglobulin A nephropathy (IgAN) is frequently employed in many Japanese institutions; however, performing this invasive treatment in patients with mild IgAN is controversial. This study aimed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50aacf74df41cfe01fefc23f131f12d6
https://doi.org/10.1007/s10157-021-02086-9
https://doi.org/10.1007/s10157-021-02086-9
Autor:
Keiko Uchida, Takahito Moriyama, Shota Ogura, Tomo Takabe, Kosaku Nitta, Kazunori Karasawa, Masayo Sato, Yuko Iwabuchi, Yoei Miyabe, Kenichi Akiyama
Publikováno v:
Blood Purification. 51:182-188
Background: In patients with systemic lupus erythematosus (SLE), disease activity can persist even after initiating dialysis. However, guidelines for the treatment of patients with SLE after dialysis is initiated have not yet been established. Case P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::154b69000e402fc62fb4f449ecd67772
https://doi.org/10.1159/000512585
https://doi.org/10.1159/000512585
Autor:
Yoshiaki Usui, Kosei Matsue, Kazuho Honda, Shota Ogura, Shigeru Horita, Hideaki Oda, Michihiro Mitobe, Sekiko Taneda, Kosaku Nitta
Publikováno v:
Kidney International Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f8183acdfc3e01939e5150cfaccc32
https://doi.org/10.1016/j.ekir.2019.09.012
https://doi.org/10.1016/j.ekir.2019.09.012
Autor:
Takahito Moriyama, Keiko Uchida, Yoei Miyabe, Shota Ogura, Kenichi Akiyama, Wataru Ono, Kosaku Nitta, Kazunori Karasawa, Ken Tuchiya, Tomo Takabe, Naoko Sugiura, Norio Hanafusa, Mizuki Kyoda, Nobue Tanaka
Publikováno v:
Clinical and Experimental Nephrology. 24:136-142
The clinical characteristics and treatment of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) after initiating chronic hemodialysis remain unknown. We retrospectively enrolled 11 adult patients with AAV receiving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ccd49b7799d225297e8f13b5a121a57
https://doi.org/10.1007/s10157-019-01799-2
https://doi.org/10.1007/s10157-019-01799-2
Autor:
Yuko Iwabuchi, Shota Ogura, Keiko Uchida, Kosaku Nitta, Naoko Sugiura, Momoko Seki, Yoei Miyabe, Kazunori Karasawa, Tomo Takabe, Norio Hanafusa, Kenichi Akiyama, Takahito Moriyama
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
The Oxford classification of IgA nephropathy (IgAN) can evaluate each MEST-C score individually. We analysed a new grading system that utilised the total MEST-C score in predicting renal prognosis. Altogether, 871 IgAN patients were classified into t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::429fc05d4f324d7c1636465104fbe936
http://europepmc.org/articles/PMC7878747
http://europepmc.org/articles/PMC7878747
Autor:
Keiko Uchida, Takahito Moriyama, Yoei Miyabe, Kosaku Nitta, Yuko Iwabuchi, Naoko Sugiura, Kenichi Akiyama, Momoko Seki, Tomo Takabe, Kazunori Karasawa, Shota Ogura
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
The Oxford classification for IgA nephropathy (IgAN) was updated in 2017. We have validated the revised Oxford classification considering treatment with corticosteroids/immunosuppressors. In this retrospective analysis, 871 IgAN patients were enrolle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aab3641a54c67e5e6aa989e6857151f
https://doi.org/10.1038/s41598-020-68087-y
https://doi.org/10.1038/s41598-020-68087-y
Autor:
Tomo Takabe, Yoei Miyabe, Kenichi Akiyama, Keiko Uchida, Norio Hanafusa, Takahito Moriyama, Kosaku Nitta, Shota Ogura, Momoko Seki, Kazunori Karasawa, Naoko Sugiura, Yuko Iwabuchi
Publikováno v:
Kidney360
Background Tonsillectomy may treat IgA nephropathy (IgAN) by reducing the levels of galactose-deficient IgA1. Therefore, we aimed to analyze the long-term effects of tonsillectomy on patients with IgAN, as an initial treatment and as a treatment at a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294c06564f854e09b87e89c7d68d3c45
https://pubmed.ncbi.nlm.nih.gov/35372877
https://pubmed.ncbi.nlm.nih.gov/35372877
Autor:
Shota Ogura, Kazunori Karasawa, Wataru Ono, Ayaki Ito, Momoko Seki, Yoshiko Yamaguchi, Miwa Kamizawa, Mai Tosaka, Yusuke Ushio, Naoko Sugiura, Tomo Takabe, Yoei Miyabe, Yuko Iwabuchi, Kenichi Akiyama, Masayo Sato, Takahito Moriyama, Keiko Uchida, Kosaku Nitta
Background: In patients with systemic lupus erythematosus (SLE), disease activity can persist even after initiating dialysis. However, guidelines for the treatment of patients with SLE after dialysis is initiated have not yet been established. Case p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13299a079666c0b5b207daafe52b0596
https://doi.org/10.21203/rs.2.24489/v1
https://doi.org/10.21203/rs.2.24489/v1
Autor:
Kosaku Nitta, Keiko Uchida, Yuko Iwabuchi, Kazunori Karasawa, Takahito Moriyama, Mizuki Kyoda, Masayo Sato, Shunji Suzuki, Yoei Miyabe, Taro Akihisa, Kenichi Akiyama, Tomo Takabe, Shun Manabe, Michiaki Kamiyama, Marie Nakano, Shota Ogura, Takahiro Kamiyama, Erika Yamaguchi
Publikováno v:
Internal Medicine
Renal disease is a common complication of rheumatoid arthritis (RA) and can occur secondary to RA or be induced by therapeutic agents. Recently, glomerular deposition of galactose-deficient IgA1 (Gd-IgA1) was identified as a feature of primary IgA va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba75ffa6d4693c2a920f658594247ef
https://pubmed.ncbi.nlm.nih.gov/31178497
https://pubmed.ncbi.nlm.nih.gov/31178497